International Dexeus Forum - 44th edition

REPRODUCTION > CANCER

“The value of AMH in assessing ovarian function and damage in women with cancer”

Richard Anderson, MRC Centre for Reproductive Health, University of Edinburgh (UK)

Is AMH a useful marker to indicate degree of ovarian protection, for example with GnRH analogues? Current status of prediction of postchemotherapy ovarian function vs failure has been studied, with implications for post-chemotherapy endocrine treatment and for future fertility.


The value of AMH in assessing ovarian function and damage in women with cancer

International Dexeus Forum - 44th edition - Richard Anderson

Request more information

(+34) 93 227 48 96

Or fill in this form and we will call you as soon as possible

I want to be informed about the latest news of Dexeus Mujer and receive the newsletter:
If you require more information, please contact our International Patient Care Unit.